Becton Dickinson and Co
BDXView Detailed Chart
198.710USD
-1.689-0.84%
Close 04/17, 16:00(ET)Quotes delayed by 15 min
57.06BMarket Cap
33.04P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.84%
5 Days
-1.49%
1 Month
-14.39%
6 Months
-18.47%
Year to Date
-12.41%
1 Year
-14.77%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
17
analysts
BUY
Current Rating
271.464
Target Price
36.61%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
111
Total
7
Median
9
Average
Company name
Ratings
Analysts
Becton Dickinson and Co
BDX
17
Medtronic PLC
MDT
34
Stryker Corp
SYK
33
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
28
Dexcom Inc
DXCM
26
1
2
3
...
22
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Sell
Indicators
Indicators
Value
Direction
MACD(12,26,9)
-3.020
Sell
RSI(14)
31.909
Neutral
STOCH(KDJ)(9,3,3)
29.009
Neutral
ATR(14)
8.325
High Vlolatility
CCI(14)
-73.238
Neutral
Williams %R
84.552
Oversold
TRIX(12,20)
-0.514
Sell
StochRSI(14)
6.701
Sell
Moving Average
Indicators
Value
Direction
MA5
201.718
Sell
MA10
203.029
Sell
MA20
215.256
Sell
MA50
222.457
Sell
MA100
226.863
Sell
MA200
230.867
Sell
News
More news coming soon, stay tuned...
Company
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Company codeBDX
CompanyBecton Dickinson and Co
CEOMr. Thomas E. Polen
Websitehttps://www.bd.com/